Medicare Enrolled
Dr. Leonard Hackett, M.D.
Hematology & Oncology · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hackett from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hackett?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hackett
Dr. Leonard Hackett is a hematology & oncology specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hackett performed 319,602 Medicare services across 7,624 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hackett received a total of $10,355 from 50 pharmaceutical and/or device companies across 353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hackett is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in CA
$10,355 industry payments
Medicare Practice Summary
Medicare Utilization ↗319,602
Medicare services
Top 1% in CA for hematology & oncology
7,624
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15,980 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
90,100 | $2 | $12 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
77,251 | $1 | $9 |
| Filgrastim-ayow biosimilar injection, 1 microgram An injection of the biosimilar medication filgrastim-ayow (Releuko) at a dose of 1 microgram. |
33,120 | $0 | $2 |
| Nivolumab injection (Opdivo) | 20,060 | $24 | $72 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
14,580 | $38 | $110 |
| Denosumab injection (Prolia/Xgeva) | 10,620 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 10,530 | $1 | $11 |
| Pembrolizumab injection (Keytruda) | 8,200 | $43 | $127 |
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
6,900 | $0 | $8 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
4,092 | $25 | $88 |
| Injection, granisetron, extended-release, 0.1 mg | 3,700 | $5 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,311 | $8 | $20 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,300 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
3,228 | $8 | $11 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,102 | $0 | $8 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
3,023 | $10 | $27 |
| Romiplostim injection, 10 micrograms An injection of romiplostim containing 10 micrograms of the medication. |
2,970 | $74 | $210 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
2,650 | $36 | $118 |
| Iron infusion (Monoferric) | 1,900 | $16 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,709 | $97 | $418 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
1,570 | $34 | $225 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,320 | $1 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,309 | $11 | $40 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
1,008 | $13 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,003 | $67 | $286 |
| Iron level test | 707 | $6 | $17 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
707 | $9 | $22 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
545 | $137 | $558 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
464 | $24 | $87 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
463 | $1 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
402 | $111 | $400 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
362 | $2 | $12 |
| Injection, leucovorin calcium, per 50 mg | 330 | $3 | $13 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
292 | $6 | $16 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
265 | $52 | $197 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
251 | $9 | $24 |
| Electrophoresis laboratory test A laboratory testing technique that separates molecules based on their size and electrical charge. |
238 | $60 | $154 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
236 | $2 | $10 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 232 | $20 | $53 |
| PSA test (prostate cancer screening) | 231 | $18 | $46 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
220 | $1 | $2 |
| Pegfilgrastim-fpgk biosimilar injection, 0.5 mg An injection of pegfilgrastim-fpgk, a biosimilar medication, administered at a dose of 0.5 mg. |
216 | $276 | $853 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
170 | $1 | $9 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 161 | $3 | $14 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
140 | $13 | $47 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
140 | $55 | $201 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
139 | $9 | $23 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
139 | $4 | $11 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
125 | $78 | $306 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
116 | $61 | $222 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
105 | $15 | $38 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
101 | $27 | $90 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
99 | $16 | $42 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
99 | $23 | $84 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 98 | $285 | $898 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
96 | $1 | $9 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
85 | $17 | $61 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
81 | $1,360 | $4,921 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
81 | $96 | $252 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
80 | $79 | $375 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 70 | $20 | $53 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
69 | $18 | $48 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
64 | $50 | $145 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
58 | $3 | $9 |
| New patient office visit, complex (60-74 min) | 55 | $160 | $594 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
52 | $12 | $32 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
49 | $14 | $37 |
| Injection, alteplase recombinant, 1 mg | 44 | $67 | $220 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
43 | $32 | $307 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
42 | $4 | $12 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
42 | $72 | $153 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
41 | $4 | $14 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
30 | $1,367 | $4,921 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
27 | $47 | $171 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
26 | $16 | $43 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $140 | $521 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
23 | $110 | $410 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
21 | $117 | $628 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
21 | $3,626 | $9,900 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
17 | $266 | $943 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
11 | $14 | $41 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.5% high complexity
67.8% medium
5.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,355
Total received (2018-2024)
Avg $1,479/year across 7 years
Top 31% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
353
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,380 (80.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,058 (10.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$917 (8.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,428
2023
$1,524
2022
$1,801
2021
$1,640
2020
$494
2019
$1,220
2018
$2,247
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$206
Celgene Corporation
$160
GlaxoSmithKline, LLC.
$149
Novartis Pharmaceuticals Corporation
$101
SEAGEN INC.
$100
Exelixis Inc.
$88
Agios Pharmaceuticals, Inc.
$75
Daiichi Sankyo Inc.
$71
ABBVIE INC.
$66
Regeneron Healthcare Solutions, Inc.
$66
E.R. Squibb & Sons, L.L.C.
$59
PFIZER INC.
$54
Lilly USA, LLC
$54
Stemline Therapeutics Inc.
$44
Ipsen Biopharmaceuticals, Inc
$38
BeiGene USA, Inc.
$20
Sirtex Medical Inc
$20
SOBI, INC
$19
Merck Sharp & Dohme LLC
$18
SERVIER PHARMACEUTICALS LLC
$14
ARRAY BIOPHARMA INC
$7
Top 3 companies account for 36.1% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,409
AstraZeneca Pharmaceuticals LP
$927
Seattle Genetics, Inc.
$917
Celgene Corporation
$783
GlaxoSmithKline, LLC.
$549
Astellas Pharma US Inc
$525
Novartis Pharmaceuticals Corporation
$490
Amgen Inc.
$400
Ipsen Biopharmaceuticals, Inc
$334
Incyte Corporation
$308
Exelixis Inc.
$278
Genentech USA, Inc.
$249
PFIZER INC.
$196
Takeda Pharmaceuticals U.S.A., Inc.
$191
Sirtex Medical Inc
$169
Pharmacyclics LLC, An AbbVie Company
$148
Regeneron Healthcare Solutions, Inc.
$139
Kite Pharma, Inc.
$138
Cardinal Health 108, LLC
$125
GENZYME CORPORATION
$123
AMAG Pharmaceuticals, Inc.
$122
Myriad Genetic Laboratories, Inc.
$120
Gilead Sciences, Inc.
$115
Progenics Pharmaceuticals, Inc.
$115
Merck Sharp & Dohme Corporation
$115
AbbVie, Inc.
$115
Daiichi Sankyo Inc.
$108
SEAGEN INC.
$100
SOBI, INC
$94
Adaptive Biotechnologies Corporation
$90
BeiGene USA, Inc.
$87
SANOFI-AVENTIS U.S. LLC
$75
Agios Pharmaceuticals, Inc.
$75
Foundation Medicine, Inc.
$72
Pharmacyclics LLC, an AbbVie Company
$70
ABBVIE INC.
$66
Myovant Sciences Inc.
$59
AVEO Pharmaceuticals, Inc.
$57
Lilly USA, LLC
$54
Stemline Therapeutics Inc.
$44
EMD Serono, Inc.
$36
PharmaEssentia USA Corporation
$36
Karyopharm Therapeutics Inc.
$30
Merck Sharp & Dohme LLC
$18
Acrotech Biopharma LLC
$16
Janssen Biotech, Inc.
$16
Apellis Pharmaceuticals, Inc.
$15
Deciphera Pharmaceuticals Inc.
$14
SERVIER PHARMACEUTICALS LLC
$14
ARRAY BIOPHARMA INC
$7
Top 3 companies account for 31.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · Cabometyx · DOPTELET · Doptelet · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · HEMLIBRA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · JADENU · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · MEKINIST · MONJUVI · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PLUVICTO · PYLARIFY · PYRUKYND · Polivy · Pomalyst · QINLOCK · REBLOZYL · Revlimid · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · TAGRISSO · TASIGNA · TECENTRIQ · Tazverik · Tibsovo · Trodelvy · VENCLEXTA · VONJO · VOTRIENT · Venclexta · XALKORI · XGEVA · XPOVIO · XTANDI · Xospata · YERVOY · Yescarta · ZEJULA · clonoSEQ · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (81%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
28
Per 100K population
2.8
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hackett is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hackett experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Hackett performed 90,100 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hackett receive payments from pharmaceutical companies?
Yes. Dr. Hackett received a total of $10,355 from 50 companies across 353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hackett's costs compare to other hematology & oncology specialists in Fresno?
Dr. Hackett's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hackett) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fresno
Browse hematology & oncology specialists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology